Real-time enrollment status for this high-grade glioma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:31 PM UTC
| NCT Number | NCT06624371 |
| Recruiting Status | Recruiting |
| Condition | High-grade Glioma |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | July 22, 2025 (Jul 22, 2025) |
As of July 13, 2026: Clinical trial NCT06624371 is currently recruiting participants. This clinical trial study for high-grade glioma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06624371 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06624371 was last updated Jul 22, 2025 (July 22, 2025). HelloStudys verifies this status automatically.